Improved data quality of plate-based IgG quantification using Spark®’s enhanced optics

Comparison of the Spark reader’s standard and enhanced fluorescence optics for IgG quantification using the Valita Titer assay.

 

Introduction

Fluorescence polarization (FP) can be used to effectively analyze changes in the size of molecules, as smaller molecules tumble more rapidly in solution than larger ones. The rotation of the molecules between absorption and emission of the photon has the effect of ‘twisting’ the polarization of the light. FP is measured by exciting the solution with polarized light and measuring the intensity of light emitted in both the parallel (polarized) and perpendicular (depolarized) planes, and is expressed as a normalized difference of these two intensities, typically in millipolarization units (mP).

The Valita Titer and Valita Titer Plus assays are rapid, high-throughput FP assays for the detection of IgG antibodies with a fluorescently-labeled protein G derivative. These assays exploit the fact that the unbound fluorescently-labeled marker tumbles more rapidly and depolarizes the light more than when it is bound to an IgG, which is around 20 times larger (Figure 1).

 

Assay schematic of ValitaTiter Plus assay for IgG quantification using FP. 

Figure 1 Assay schematic of Valita Titer Plus assay for IgG quantification using FP. Each well of the plate is pre-coated with a fluorescently-labeled IgG-specific probe (1). IgG in a sample binds to the probe (2). Binding is measured via FP and rotational diffusion (3).

Figure 1: Assay schematic of Valita Titer Plus assay for IgG quantification using FP. Each well of the plate is pre-coated with a fluorescently-labeled IgG-specific probe (1). IgG in a sample binds to the probe (2). Binding is measured via FP and rotational diffusion (3). The choice of plate reader, optics and measurement settings all significantly affect the quality of the data for FP assays. For Valita Titer assays, the power and frequency of the flash lamp used for sample excitation are critical, together with the choice of optical system used for wavelength selection; filter optics are more sensitive but less flexible, whereas monochromators are more flexible but less sensitive. The Spark multimode microplate reader offers FP with filters, monochromators or Fusion Optics that combine filters and monochromators in the same measurement. Additionally, the platform is available with standard optics – using a 5 W, 50 Hz xenon flash lamp – or with enhanced optics, using a 20 W, 100 Hz xenon flash lamp.

The power and the frequency of the flash lamp are very important for the throughput of a reader, as these determine the number of flashes and the measurement time required to obtain the desired data quality. The modular concept of the Spark allows users to combine different optical components to match their throughput, sensitivity and flexibility requirements. It also allows the addition of other read modes – including fluorescence intensity, absorbance, luminescence or brightfield imaging – making the Spark a multifunctional instrument that can support many lab assays. This technical note outlines the use of the Spark reader in combination with the Valita Titer assay for the quantification of IgG. It offers a comparison of the use of the instrument’s standard and enhanced fluorescence optics, and discusses the optimization of flash number to produce high quality, reproducible data while minimizing read times.

 

Materials

  • 2 x Valita Titer (Gen 2) assay plates
  • Spark multimode microplate reader with standard optics
  • Spark multimode microplate reader with enhancedoptics
  • Native human IgG standard (#5172-9017, BioRad)
  • Gibco® CD CHO medium (#10743, ThermoFisher)
     

Method

Native human IgG standard was reconstituted in PBS to a concentration of 5 mg/L (±0.5 %) as per the manufacturer’s instructions. Serial dilutions were then performed in CD CHO media to prepare an 8-point standard curve ranging from 0 mg/l to 200 mg/L. The assay protocol was performed using single and multichannel pipettes as follows: 

  1. 60 μl of cell culture media was added to each well to reconstitute the IgG-specific probe (pre-dried onto the surface of the ValitaTiter assay plate).
  2. 60 μl of each standard was then added into appropriate wells and run in replicates across a 96-well plate.
  3. A multichannel pipette was used to mix each well 3 times prior to a 5-minute incubation in the dark.
  4. Each plate was then read using the two Spark instruments (individual instrument settings are outlined in Table 1 and Table 2, respectively).
  5. Each plate was read 6 times, with the only variable being the flash number. The gain and z-position were kept constant from the first read to allow plate-to-plate comparability.

 

 

 Instrument settings for ValitaTiter assay measurement on the Spark with standard monochromator optics.

Table 1 Instrument settings for Valita Titer assay measurement on the Spark with standard monochromator optics.

 

 Instrument settings for ValitaTiter assay measurement on the Spark with enhanced monochromator optics.

Table 2 Instrument settings for Valita Titer assay measurement on the Spark with enhanced monochromator optics.

 

Results

An investigation into the effect of flash number on the reproducibility and assay read time of replicate IgG standard curves was carried out, comparing Spark’s standard monochromator optics with the enhanced monochromator optics. Reproducibility was determined by comparing the average standard deviation (SD) obtained between replicate samples across an entire 96-well plate, at varying IgG concentrations, for each flash number (30, 40, 50, 60, 80 and 100 flashes). Figure 2 provides an overview of the data, where the average SD is plotted against IgG concentration (in mg/L) for each flash number.

It is clear from the results that, when using the standard optics (Figure 2a), a high flash number (>80 flashes) is required to reduce the SD between replicate samples to an acceptable range (SD <2). This increases the read time and, therefore, the overall data acquisition time (Figure 3). In contrast, the enhanced optics reduce the need for a high flash number in order to obtain reproducible data (Figure 2b). Using this set-up, 30 flashes (the minimum tested) led to the production of acceptable data in a fraction of the time (Figure 3).

 

Scatter plots of showing impact of flash number on standard deviations with (a) standard optics and (b) enhanced optics.

 

Scatter plots of showing impact of flash number on standard deviations with (a) standard optics and (b) enhanced optics.

Figure 2 Scatter plots showing impact of flash number on standard deviations with (a) standard optics and (b) enhanced optics.

 

 

Scatter plot of time versus flash number for measurement of a 96-well plate using the Spark instrument’s standard optics (black squares) and enhanced optics (grey circles).

Figure 3 Scatter plot of time versus flash number for measurement of a 96-well plate using the Spark instrument’s standard optics (black squares) and enhanced optics (grey circles).

 
  

Conclusion

The data presented here demonstrates the suitability of the Spark multimode microplate reader for IgG quantification using ValitaCell’s Valita Titer assay, achieving reproducible and reliable data. It provides an overview of how one parameter – in this case flash number – can significantly affect both the reproducibility between replicates and the overall read times. Selection of the optical system of the reader should therefore match the throughput demands of the lab to allow sufficient read times per plate. The fast and powerful xenon flash lamp of Spark’s enhanced optics is ideal for high-throughput demands, whereas the standard optics provide a cost-effective solution for labs with lower throughput demands.

 


For Research Use Only. Not for use in diagnostic procedures.
Tecan Group Ltd. makes every effort to include accurate and up-to-date information within this publication; however, it is possible that omissions or errors might have occurred. Tecan Group Ltd. cannot, therefore, make any representations or warranties, expressed or implied, as to the accuracy or completeness of the information provided in this publication. Changes in this publication can be made at any time without notice. For technical details and detailed procedures of the specifications provided in this document please contact your Tecan representative. This brochure may contain reference to applications and products which are not available in all markets. Please check with your local sales representative.
All mentioned trademarks are protected by law. In general, the trademarks and designs referenced herein are trademarks, or registered trademarks, of Tecan Group Ltd., Mannedorf, Switzerland. A complete list may be found at www.tecan.com/trademarks. Product names and company names that are not contained in the list but are noted herein may be the trademarks of their respective owners.
Tecan and Spark are registered trademarks of Tecan Group Ltd., Männedorf, Switzerland.
GIBCO® is a registered trademark of Life Technologies Corp., Carlsbad, CA, US (a subsidiary of Thermo Fisher Scientific Inc.).
Valita, Valita Titer and the ValitaCell logo are trademarks or registered trademarks of ValitaCell in the United States and other countries. ValitaCell is a Beckman Coulter Company.
This method is for demonstration only, and is not validated by Beckman Coulter. Beckman Coulter makes no warranties of any kind whatsoever express or implied, with respect to this protocol, including but not limited to warranties of fitness for a particular purpose or merchantability or that the protocol is non-infringing. All warranties are expressly disclaimed. Your use of the method is solely at your own risk, without recourse to Beckman Coulter. Not intended or validated for use in the diagnosis of disease or other conditions
© 2020, Tecan Trading AG, Switzerland, all rights reserved. For disclaimer and trademarks please visit www.tecan.com.

Want to learn more about Valita Titer assays?
Request a demo today